title: Selepressin in Septic Shock: A Step Toward Decatecholaminization?
authors.affiliation: Département de Réanimation Médicale et de Médecine Hyperbare, Centre Hospitalier Universitaire, Angers, FranceCenter for Heart Lung Innovation, Division of Critical Care Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, CanadaInstitut für Molekulare Endokrinologie der Tiere, Universität Ulm, Ulm, GermanyInstitut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum, Ulm, Germany.
authors.forename: Pierre
authors.initials: P
authors.lastname: Asfar
authors.forename: James A
authors.initials: JA
authors.lastname: Russell
authors.forename: Jan
authors.initials: J
authors.lastname: Tuckermann
authors.forename: Peter
authors.initials: P
authors.lastname: Radermacher
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D005260:Female; D009638:Norepinephrine / Q000627:therapeutic use*; D017483:Receptors, Vasopressin / Q000819:agonists*; D012757:Sheep Diseases / Q000188:drug therapy*; D012772:Shock, Septic / Q000662:veterinary*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014667:Vasopressins / Q000627:therapeutic use*
chemical_list: D017483:Receptors, Vasopressin; D014662:Vasoconstrictor Agents; D014667:Vasopressins; D001127:Arginine Vasopressin; D009638:Norepinephrine